MX2009012179A - Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma. - Google Patents

Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma.

Info

Publication number
MX2009012179A
MX2009012179A MX2009012179A MX2009012179A MX2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A
Authority
MX
Mexico
Prior art keywords
melanoma
treatment
pharmaceutically acceptable
acceptable salt
hdac inhibitor
Prior art date
Application number
MX2009012179A
Other languages
English (en)
Inventor
Peter Wisdom Atadja
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39641895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009012179(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009012179A publication Critical patent/MX2009012179A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere al uso de un inhibidor de desacetilasa de histona, más específicamente a una sal farmacéuticamente aceptable del mismo, para la fabricación de composiciones farmacéuticas para el tratamiento de melanoma; al uso de un inhibidor de desacetilasa de histona o una sal farmacéuticamente aceptable del mismo, en el tratamiento de melanoma; a un método para el tratamiento de animales de sangre caliente, incluyendo mamíferos, en especial seres humanos, que sufran de melanoma, mediante la administración a este animal que necesite dicho tratamiento, de una dosis efectiva contra la enfermedad mencionada, de un inhibidor de desacetilasa de histona o una sal farmacéuticamente aceptable del mismo.
MX2009012179A 2007-05-11 2008-05-09 Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma. MX2009012179A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91734507P 2007-05-11 2007-05-11
US93827207P 2007-05-16 2007-05-16
PCT/US2008/063136 WO2008141114A1 (en) 2007-05-11 2008-05-09 Use of hdac inhibitors for the treatment of melanoma

Publications (1)

Publication Number Publication Date
MX2009012179A true MX2009012179A (es) 2009-12-01

Family

ID=39641895

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012179A MX2009012179A (es) 2007-05-11 2008-05-09 Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma.

Country Status (15)

Country Link
US (2) US20110034531A1 (es)
EP (1) EP2155193A1 (es)
JP (1) JP2010526830A (es)
KR (1) KR20100016376A (es)
CN (1) CN101677995A (es)
AU (1) AU2008251499A1 (es)
CA (1) CA2684114A1 (es)
CL (1) CL2008001363A1 (es)
IL (1) IL201439A0 (es)
MA (1) MA31365B1 (es)
MX (1) MX2009012179A (es)
RU (1) RU2009145803A (es)
TN (1) TN2009000449A1 (es)
TW (1) TW200911231A (es)
WO (1) WO2008141114A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)

Also Published As

Publication number Publication date
CA2684114A1 (en) 2008-11-20
AU2008251499A1 (en) 2008-11-20
CL2008001363A1 (es) 2008-12-19
US20110034531A1 (en) 2011-02-10
JP2010526830A (ja) 2010-08-05
TW200911231A (en) 2009-03-16
TN2009000449A1 (en) 2011-03-31
RU2009145803A (ru) 2011-06-20
IL201439A0 (en) 2010-05-31
MA31365B1 (fr) 2010-05-03
US20110288144A1 (en) 2011-11-24
WO2008141114A1 (en) 2008-11-20
KR20100016376A (ko) 2010-02-12
EP2155193A1 (en) 2010-02-24
CN101677995A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
MX368368B (es) Compuestos de indol e indazol como un inhibidor de necrosis celular.
EA201170473A1 (ru) Морфинановые соединения
EA201101507A1 (ru) Способы лечения солидных опухолей
EA201290919A1 (ru) Индазольные соединения и их применение
MY162157A (en) Substituted indole mcl-1 inhibitors
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
UA100116C2 (ru) Профилактика или лечение воспалительного заболевания
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
ZA200806778B (en) N-Hydroxyacrylamide compounds
MX346186B (es) Inhibidores de proteina cinasas.
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2009005649A (es) Tratamiento para mieloma multiple.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
GT200600160A (es) Tratamiento del dolor
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
EA201490552A1 (ru) Холиновая соль замещенного циклобутендиона, обладающая противовоспалительной способностью
MX2014007969A (es) Hidroxiamidas de ácido cinámico como inhibidores de la histona desacetilasa 8.
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
EA201170344A1 (ru) Азаиндольные ингибиторы iap
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2013002649A (es) Agente terapeutico contra el dolor.
TN2009000486A1 (en) Raf inhibitors for the treatment of thyroid cancer

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal